Kapitalo Investimentos Ltda Acquires New Holdings in Kenvue Inc. $KVUE

Key Points

• Kapitalo Investimentos initiated a Kenvue position by purchasing 58,000 shares worth approximately $1.1 million. Institutional investors own 97.64% of the company.
• Analyst sentiment remains cautious, with an overall “Hold” rating and a consensus price target of $19.27. UBS and other firms recently lowered or maintained neutral ratings, while Barclays raised its target to $19.
• Kenvue slightly missed quarterly earnings and revenue expectations, but revenue increased 3% year over year. The company maintains a quarterly dividend of $0.21, equivalent to an annualized yield of about 4.3%.

Kapitalo Investimentos Ltda bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 58,000 shares of the company's stock, valued at approximately $1,108,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Johnson Financial Group Inc. bought a new stake in shares of Kenvue in the 2nd quarter worth approximately $26,000. CoreCap Advisors LLC lifted its stake in Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock valued at $29,000 after purchasing an additional 591 shares during the last quarter. Elyxium Wealth LLC bought a new stake in Kenvue during the fourth quarter worth approximately $26,000. Physician Wealth Advisors Inc. boosted its holdings in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock worth $26,000 after buying an additional 618 shares in the last quarter. Finally, MV Capital Management Inc. acquired a new position in Kenvue in the fourth quarter worth approximately $28,000. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on KVUE. UBS Group cut their target price on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 11th. Zacks Research cut Kenvue from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 15th. Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, Barclays raised their target price on shares of Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $19.27.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $19.34 on Wednesday. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $21.40. The business has a fifty day simple moving average of $19.10 and a 200 day simple moving average of $18.22. The firm has a market cap of $37.16 billion, a price-to-earnings ratio of 22.24, a P/E/G ratio of 1.39 and a beta of 0.47.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The firm had revenue of $3.96 billion for the quarter, compared to analysts' expectations of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm's revenue for the quarter was up 3.0% on a year-over-year basis. During the same period last year, the business earned $0.29 earnings per share. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 4.3%. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 12th. Kenvue's dividend payout ratio is presently 96.55%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source